18 
1 biohazard committees has been variously estimated at 4 
2 to 15 percent by NIH's Office of Recombinant DNA Acti- 
3 vities. The turn-around ti^e for that office's review 
4 of an IBC assessment of containment requirements is only 
5 four to five days. For these two reasons, EDF maintains 
6 that no changes should be allowed without ORDA approval. 
7 And to speed up the turn-around time, EDF suggests that 
8 ORDA be given additional staff. There are presently only 
9 two people reviewing IBC assessments of containment 
10 guidelines. 
^ Finally, EDF suggests that IBC's be required 
12 to conduct semi-annual inspections of laboratories engaged 
13 in recombinant DNA research and submit such reports of 
14 inspections to ORDA and have them publicly available. 
^ Again, this has only been a brief summary of 
16 our concerns, and only a brief summary of our thoughts. 
17 Thank you. 
MR. LI 3 ASSI : Thank you very much. Any questions 
10 
19 from anyone? 
2Q Thank you. 
The next witness is Dr. June Osborn. 
22 DR. OSBORN: I am June Osborn, and I am a 
23 Professor of Medical Microbiology and Pediatrics at the 
2 4 University of Wisconsin at Madison. 
My purpose in making a comment concerning the 
ZD 
[ 110 ] 
